Figures & data
Figure 1. Observation of C2C12 proliferation, differentiation, and fusion. (A) Cells were cultured in basal or differentiation condition for 7 days and observed under light microscope (× 100). (B) Cells were cultured in proliferation or differentiation medium for 4 days and revealed by immunostaining with MyoD1, myogenin or myosin antibody (green). Nuclei are labeled using DAPI (blue).
![Figure 1. Observation of C2C12 proliferation, differentiation, and fusion. (A) Cells were cultured in basal or differentiation condition for 7 days and observed under light microscope (× 100). (B) Cells were cultured in proliferation or differentiation medium for 4 days and revealed by immunostaining with MyoD1, myogenin or myosin antibody (green). Nuclei are labeled using DAPI (blue).](/cms/asset/d785b00d-934b-416e-9150-4365a7435a98/irab_a_2013574_f0001_c.jpg)
Figure 2. Effects of 5 Gy irradiation on C2C12 proliferation in basal or differentiation conditions. C2C12 cells were grown for 3 days, irradiated and counted 2, 4 and 7 days after irradiation. (A) Cells were counted under microscope or (B) proliferation/viability assay was performed with PrestoBlueTM. *p < 0.05, ** p < 0.01, *** p < 0.001 (ANOVA) denotes (A) the number of cells or (B) the level of absorbance in irradiated C1C12 vs. the same measure in control non-irradiated C2C12.
![Figure 2. Effects of 5 Gy irradiation on C2C12 proliferation in basal or differentiation conditions. C2C12 cells were grown for 3 days, irradiated and counted 2, 4 and 7 days after irradiation. (A) Cells were counted under microscope or (B) proliferation/viability assay was performed with PrestoBlueTM. *p < 0.05, ** p < 0.01, *** p < 0.001 (ANOVA) denotes (A) the number of cells or (B) the level of absorbance in irradiated C1C12 vs. the same measure in control non-irradiated C2C12.](/cms/asset/73af60cd-83c0-4edc-b15a-754d0fe3fa9a/irab_a_2013574_f0002_b.jpg)
Figure 3. Effects of 5 Gy irradiation over time in basal or differentiation conditions on relative expression of (A) Pax3, (B) MyoG, (C) ENO3. Cells were grown for 3 days prior to irradiation and then cultured in basal or differentiation conditions. RT-qPCR was performed 2, 4 and 7 days after irradiation and the relative expression (2−ΔΔCt) of (A) Pax3, (B) MyoG and (C) ENO3 was measured. Expression is normalized to the HPRT reference gene and to the day 0 condition. (D) Cells were grown 3 days prior to irradiation then cultured in proliferation or differentiation medium for 4 days and revealed by immunostaining with myogenin antibody (green). (E) Western Blot of myogenin was performed with cells cultured in the same way. *p < 0.05, **p < 0.01, ***p < 0.001 (ANOVA) denotes level of absorbance in irradiated C1C12 vs. level in the same condition but non-irradiated C2C12, #p < 0.05, ##p < 0.01, ###p < 0.001 (ANOVA) indicate significant difference between groups below the vertical dotted lines.
![Figure 3. Effects of 5 Gy irradiation over time in basal or differentiation conditions on relative expression of (A) Pax3, (B) MyoG, (C) ENO3. Cells were grown for 3 days prior to irradiation and then cultured in basal or differentiation conditions. RT-qPCR was performed 2, 4 and 7 days after irradiation and the relative expression (2−ΔΔCt) of (A) Pax3, (B) MyoG and (C) ENO3 was measured. Expression is normalized to the HPRT reference gene and to the day 0 condition. (D) Cells were grown 3 days prior to irradiation then cultured in proliferation or differentiation medium for 4 days and revealed by immunostaining with myogenin antibody (green). (E) Western Blot of myogenin was performed with cells cultured in the same way. *p < 0.05, **p < 0.01, ***p < 0.001 (ANOVA) denotes level of absorbance in irradiated C1C12 vs. level in the same condition but non-irradiated C2C12, #p < 0.05, ##p < 0.01, ###p < 0.001 (ANOVA) indicate significant difference between groups below the vertical dotted lines.](/cms/asset/40448719-5095-47fe-b786-7047a856846d/irab_a_2013574_f0003_c.jpg)
Figure 4. Effects of Hh pathway modulation on cell proliferation in basal condition after irradiation. C2C12 cells were grown 3 days prior to irradiation, then treated with Shh 4 ug/mL or Cyclopamine 3 mM, and 4 days after irradiation proliferation/viability assay was performed with PrestoBlueTM. ***p < 0.001 (ANOVA) denotes level of absorbance in irradiated C1C12 vs. level in control non-irradiated C2C12, #p < 0.05, ##p < 0.01, ###p < 0.001 (ANOVA) indicate significant difference between groups below the vertical dotted lines.
![Figure 4. Effects of Hh pathway modulation on cell proliferation in basal condition after irradiation. C2C12 cells were grown 3 days prior to irradiation, then treated with Shh 4 ug/mL or Cyclopamine 3 mM, and 4 days after irradiation proliferation/viability assay was performed with PrestoBlueTM. ***p < 0.001 (ANOVA) denotes level of absorbance in irradiated C1C12 vs. level in control non-irradiated C2C12, #p < 0.05, ##p < 0.01, ###p < 0.001 (ANOVA) indicate significant difference between groups below the vertical dotted lines.](/cms/asset/a124f26c-1c4c-4214-9e8f-e8fd7b222077/irab_a_2013574_f0004_b.jpg)
Figure 5. Effects of Hh pathway modulation on cell apoptosis after irradiation. Cells were grown for 3 days, irradiated, and treated with Shh 4 μg/mL or Cyclopamine 3 mM. At day 2, survival analyses were performed using TUNEL technique in basal and differentiation media for cells treated (A) with Shh 4 μg/mL or (B) with Cyclopamine 3 mM. (C) Representative fields obtained in differentiation condition are presented. Apoptotic cells are labeled with Alexa Fluor 488 (green spots) and nuclei with DAPI (blue). Fluorescence microscopy ×100, scale bar = 200 µm. ***p < 0.001 (ANOVA) denotes level of absorbance in irradiated C1C12 vs. level in the same conditions but non-irradiated C2C12, ##p < 0.01, ###p < 0.001 (ANOVA) indicate significant difference between groups below the vertical dotted lines.
![Figure 5. Effects of Hh pathway modulation on cell apoptosis after irradiation. Cells were grown for 3 days, irradiated, and treated with Shh 4 μg/mL or Cyclopamine 3 mM. At day 2, survival analyses were performed using TUNEL technique in basal and differentiation media for cells treated (A) with Shh 4 μg/mL or (B) with Cyclopamine 3 mM. (C) Representative fields obtained in differentiation condition are presented. Apoptotic cells are labeled with Alexa Fluor 488 (green spots) and nuclei with DAPI (blue). Fluorescence microscopy ×100, scale bar = 200 µm. ***p < 0.001 (ANOVA) denotes level of absorbance in irradiated C1C12 vs. level in the same conditions but non-irradiated C2C12, ##p < 0.01, ###p < 0.001 (ANOVA) indicate significant difference between groups below the vertical dotted lines.](/cms/asset/6ff7bf0c-9248-4fce-8e19-a46bad50fc8d/irab_a_2013574_f0005_c.jpg)
Figure 6. Effect of Hh pathway activation by Shh on C2C12 after irradiation. Cells were grown for 3 days, irradiated, treated with Shh 4 μg/mL and 4 days after irradiation RT-qPCR was performed and relative expression (2−ΔΔCt) of (A) MyoG and (B) MyHC was measured. Expression is normalized to the HPRT reference gene and to the basal 0 Gy condition. (C) WesternBlot of the corresponding proteins was performed with cells cultured in the same way. **p < 0.01, ***p < 0.001 (t-test) denotes level of absorbance in irradiated C1C12 vs. level in the same conditions but non-irradiated C2C12, #p < 0.05, ##p < 0.01, ###p < 0.001 (t-test) indicate significant difference between groups below the vertical dotted lines.
![Figure 6. Effect of Hh pathway activation by Shh on C2C12 after irradiation. Cells were grown for 3 days, irradiated, treated with Shh 4 μg/mL and 4 days after irradiation RT-qPCR was performed and relative expression (2−ΔΔCt) of (A) MyoG and (B) MyHC was measured. Expression is normalized to the HPRT reference gene and to the basal 0 Gy condition. (C) WesternBlot of the corresponding proteins was performed with cells cultured in the same way. **p < 0.01, ***p < 0.001 (t-test) denotes level of absorbance in irradiated C1C12 vs. level in the same conditions but non-irradiated C2C12, #p < 0.05, ##p < 0.01, ###p < 0.001 (t-test) indicate significant difference between groups below the vertical dotted lines.](/cms/asset/3a217dfa-4746-4bb6-b9a3-54cd4908575d/irab_a_2013574_f0006_b.jpg)
Figure 7. Effect of Hh pathway blockade by Cyclopamine on C2C12 after irradiation. Cells were grown for 3 days, irradiated, treated with Cyclopamine 3 mM and 4 days after irradiation RT-qPCR was performed and relative expression (2−ΔΔCt) of (A) MyoG and (B) MyHC was measured. Expression is normalized to the HPRT reference gene and to the basal 0 Gy condition. (C) Western Blot of the corresponding proteins was performed with cells cultured in the same way. **p < 0.01, ***p < 0.001 (t-test) denotes level of absorbance in irradiated C1C12 vs. level in the same conditions but non-irradiated C2C12, #p < 0.05, ##p < 0.01, ###p < 0.001 (t-test) indicate significant difference between groups below the vertical dotted lines.
![Figure 7. Effect of Hh pathway blockade by Cyclopamine on C2C12 after irradiation. Cells were grown for 3 days, irradiated, treated with Cyclopamine 3 mM and 4 days after irradiation RT-qPCR was performed and relative expression (2−ΔΔCt) of (A) MyoG and (B) MyHC was measured. Expression is normalized to the HPRT reference gene and to the basal 0 Gy condition. (C) Western Blot of the corresponding proteins was performed with cells cultured in the same way. **p < 0.01, ***p < 0.001 (t-test) denotes level of absorbance in irradiated C1C12 vs. level in the same conditions but non-irradiated C2C12, #p < 0.05, ##p < 0.01, ###p < 0.001 (t-test) indicate significant difference between groups below the vertical dotted lines.](/cms/asset/4ff93028-1103-41ec-9955-c1f80190a62c/irab_a_2013574_f0007_b.jpg)